Novartis Nederland
Pharmaceutical ManufacturingNorth Holland, Netherlands51-200 Employees
Novartis Nederland operates as the Dutch arm of the Swiss pharmaceutical manufacturer Novartis, based in Amsterdam, North Holland. The organization is active in pharmaceutical manufacturing and focuses on translating the latest scientific insights into new therapies aimed at improving patient outcomes and extending life. The local team is around 300 people and works within the One Novartis Nederland initiative. Globally, the Novartis group employs about 107,000 people from diverse nationalities, and its medicines reach an estimated 800 million people worldwide. The company places substantial emphasis on research and development within the pharmaceutical sector. In 2019, Pharming Group N.V. entered into a licensing agreement with Novartis to develop and commercialize CDZ173, a PI3K delta inhibitor intended for Activated PI3K Delta Syndrome, illustrating collaboration activity.